Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study.

In contrast, in the subgroup of patients with a baseline Hb level of ≥10.4 to <11.0 g/dL and those with an Hb level of ≥11.0 g/dL, a decreasing trend in Hb levels in the early treatment period was observed ( Figure 2a ).

also in 47,180 other papers